CLINICAL_TRIALS
trial_result
· 2022-12-09
Clinical Trial Update: Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata [Phase 2]
Summary
A Phase 2 clinical trial evaluating two dose regimens of CTP-543 in adults with alopecia areata has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Concert Pharmaceuticals | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2022-12-09